ATE494555T1 - Verfahren in verbindung mit einer hepatitis-b- infektion - Google Patents

Verfahren in verbindung mit einer hepatitis-b- infektion

Info

Publication number
ATE494555T1
ATE494555T1 AT04818749T AT04818749T ATE494555T1 AT E494555 T1 ATE494555 T1 AT E494555T1 AT 04818749 T AT04818749 T AT 04818749T AT 04818749 T AT04818749 T AT 04818749T AT E494555 T1 ATE494555 T1 AT E494555T1
Authority
AT
Austria
Prior art keywords
hepatitis
infection
procedure related
individual
pres1
Prior art date
Application number
AT04818749T
Other languages
English (en)
Inventor
Ulla Hellstrom
Staffan Sylvan
Original Assignee
Hbv Theranostica Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hbv Theranostica Ab filed Critical Hbv Theranostica Ab
Priority claimed from PCT/EP2004/011958 external-priority patent/WO2005050214A2/en
Application granted granted Critical
Publication of ATE494555T1 publication Critical patent/ATE494555T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/576—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis
    • G01N33/5761—Hepatitis B
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2469/00—Immunoassays for the detection of microorganisms
    • G01N2469/20—Detection of antibodies in sample from host which are directed against antigens from microorganisms

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Communicable Diseases (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT04818749T 2003-11-12 2004-10-22 Verfahren in verbindung mit einer hepatitis-b- infektion ATE494555T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US51915203P 2003-11-12 2003-11-12
GBGB0326416.5A GB0326416D0 (en) 2003-11-12 2003-11-12 Methods and means relating to hepatitis B infection
PCT/EP2004/011958 WO2005050214A2 (en) 2003-11-12 2004-10-22 Methods and means relating to hepatitis b infection

Publications (1)

Publication Number Publication Date
ATE494555T1 true ATE494555T1 (de) 2011-01-15

Family

ID=29726432

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04818749T ATE494555T1 (de) 2003-11-12 2004-10-22 Verfahren in verbindung mit einer hepatitis-b- infektion

Country Status (5)

Country Link
US (1) US8076085B2 (de)
CN (1) CN1906488A (de)
AT (1) ATE494555T1 (de)
DE (1) DE602004030936D1 (de)
GB (1) GB0326416D0 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100949310B1 (ko) * 2007-11-21 2010-03-23 한국과학기술연구원 세포 영상 기법을 이용한 ｈｂｖ 캡시드 단백질과 표면단백질 간 상호작용 측정 방법과 이를 이용한 ｈｂｖ 증식억제물질의 검색방법
EP2629096A1 (de) * 2012-02-20 2013-08-21 Roche Diagniostics GmbH HBV-Immunkomplexe zur Reaktionsvorhersage und Therapieüberwachung bei chronischen HBV-Patienten

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5204096A (en) * 1984-03-07 1993-04-20 New York Blood Center, Inc. Pre-S gene coded peptide hepatitis B immunogens, vaccines, diagnostics, and synthetic lipid vesicle carriers
US4847080A (en) * 1984-03-07 1989-07-11 New York Blood Center, Inc. Pre-S gene coded peptide hepatitis B immunogens, vaccines, diagnostics, and synthetic lipide vesicle carriers
WO1987007896A1 (en) 1986-06-20 1987-12-30 Scripps Clinic And Research Foundation T and b cell epitopes of the pre-s region of hepatitis b virus surface antigen
EP0491077A1 (de) 1990-12-19 1992-06-24 Medeva Holdings B.V. Zusammensetzung verwendbar als therapeutisches Mittel gegen chronische virale Leberkrankheiten
AU4996493A (en) 1992-08-21 1994-03-15 Abbott Laboratories Methods for monitoring effectiveness of interferon therapy in individuals with hcv infections

Also Published As

Publication number Publication date
DE602004030936D1 (de) 2011-02-17
US8076085B2 (en) 2011-12-13
GB0326416D0 (en) 2003-12-17
CN1906488A (zh) 2007-01-31
US20070054264A1 (en) 2007-03-08

Similar Documents

Publication Publication Date Title
ZA202104213B (en) Antibodies that neutralize hepatitis b virus and uses thereof
DK1294893T3 (da) Modifikation af hepatitis B-kerneantigen
CY1108789T1 (el) Καθαρισμος αντιγονων hbv για χρηση σε εμβολια
DE60317659D1 (de) Unterdruckpumpe und verfahren zur erzeugung von unterdruck
DK0726758T3 (da) Peptider til inducering af cytotoksiske T-lymfocytreaktioner over for hepaptitis B virus
SG10201806025TA (en) Neutralizing human monoclonal antibodies against hepatitis b virus surface antigen
DE602004024921D1 (de) Zusammensetzungen und verfahren zur behandlung von tumoren hämatopoetischen ursprungs
ATE473997T1 (de) Zur bildung von partikeln fähiges hbv-precore- protein
DE10085168T1 (de) Verfahren zur Ausbildung von Oberflächengrübchen und Bauteil mit Oberflächengrübchen
DE60123042D1 (de) L-fmau zur behandlung von hepatitis-delta-virus-infizierung
DE602004030936D1 (de) Verfahren in verbindung mit einer hepatitis-b-infektion
DK88988D0 (da) T- og b-celleepitoper af pre-s-regionen af hepatitis-b-virus-overfladeantigen
WO2005050214A3 (en) Methods and means relating to hepatitis b infection
PT1766098E (pt) Anticorpos monoclonais de coelho para antigénios de superfície da hepatite b e métodos para utilizar os mesmos
WO2020254878A8 (en) Improved therapeutic composition comprising hepatitis b antigen having s, pre-s1 and pre-s2 protein, aluminium phosphate and interferon-alpha and use thereof for treatment of hepatitis b.
ATE552264T1 (de) Neue oberflächenprotein- (hbsag-) variante des hepatitis b virus
IL161138A0 (en) Treatment of hepatitis b virus infection with human monoclonal antibodies
CA3295996A1 (en) Methods for reducing hepatitis b virus surface antigen (hbsag) and the hepatitis b drugs used in the methods thereof
DE60112390D1 (de) Verfahren zur Herstellung von Isobuten-Isopren Kopolymeren
WO2004037202A3 (en) Gb virus c and methods of treating viral infections
DE602004024658D1 (de) Verfahren zur vermittlung von zellkulturreplikationsaktivität an unterschiedliche hepatitis-c-virus-isolate
ATE409705T1 (de) Pre-s-protein von hepatitis-b-virus (hbv) als adjuvans und komponente eines hbv-impfstoffs
EP1268749A4 (de) Diagnostische reagenzien und methoden für antikörper gegen hepatitis b oberflächenantigen und für antikörper gegen hepatitis b virus
EP0542753A4 (en) Epitopes of the pre-s region of hepatitis b virus surface antigen
TW200510545A (en) HBV pre-core protein having particle-forming ability

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties